Dr. Davis is a consultant in nonclinical pharmaceutical development, with emphasis on toxicology and pathology. He received his DVM and Ph.D. in Veterinary Pathology from Cornell University and is a Diplomat of the American College of Veterinary Pathologists. He was previously Director of Toxicology at Schering-Plough Corp (now Merck), where he directed the nonclinical programs leading to worldwide marketing approval for many drugs, including biologics and small molecules. Since 2004, he has been President and Director of Toxicology Consultation at PreclinPharma, advising on the design and management of nonclinical programs in pharmaceutical development.